Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors.
about
Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects.Lipid posttranslational modifications. Farnesyl transferase inhibitors.Recent advances in targeted therapy of human myelogenous leukaemia.From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy.Lonafarnib in cancer therapy.Investigating mammalian target of rapamycin inhibitors for their anticancer properties.Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer.Protein kinases as targets for cancer treatment.Progression of endocrine therapies for breast cancer: where are we headed?The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer.Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatmentOptimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer.
P2860
Q33393707-198692E0-64AD-4816-A978-FC87B266D2EFQ34651253-27C6D23B-A574-4A64-A8F2-AD6A9BBF47C0Q36318531-53C4D7C7-F70A-4A59-A06A-BD47E5F78B91Q36352100-76F49AF9-7CEB-4EBA-B121-4778DD5D1CC8Q36491847-D04DF51D-9CEA-410D-8FC6-5F6B9035A4E3Q36600294-6029E439-4CAF-4C89-8BFB-44AE2E68F8F9Q36740646-FDE61B84-4534-457F-8F99-6A497F9F8E55Q36918131-3C4B1746-5E26-4C9A-BDED-756FF47FA897Q37004695-D512F4CF-99CE-4D4C-AA0A-C231094DA416Q37141960-0B4FD48F-B77F-42DD-8112-1872627B2DE4Q38262500-70BC3FB8-C7C2-47C8-905C-F8D27887DCD8Q46186791-BFED1D3B-8F5E-439F-BF41-A219F5D3DE0C
P2860
Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Phase I pharmacokinetic and ph ...... ts with advanced solid tumors.
@en
Phase I pharmacokinetic and ph ...... ts with advanced solid tumors.
@nl
type
label
Phase I pharmacokinetic and ph ...... ts with advanced solid tumors.
@en
Phase I pharmacokinetic and ph ...... ts with advanced solid tumors.
@nl
prefLabel
Phase I pharmacokinetic and ph ...... ts with advanced solid tumors.
@en
Phase I pharmacokinetic and ph ...... ts with advanced solid tumors.
@nl
P2093
P50
P356
P1476
Phase I pharmacokinetic and ph ...... ts with advanced solid tumors.
@en
P2093
Anne Van Vreckem
Carmen Garrido
Federico Vázquez
Fredy Rojo
Irene Marimón
James A Manning
Joan Albanell
Joan Carulla
Joaquim Bellmunt
Jordi Andreu
P304
P356
10.1200/JCO.2005.00.398
P407
P577
2005-02-14T00:00:00Z